Solventum SOLV MedSurg — Total Net Sales
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Solventum in its filing.
Tagged under the XBRL concept us-gaap:Revenues.
The official record: Solventum’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Solventum's medsurg — total net sales.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Solventum's medsurg — total net sales?
- Solventum (SOLV) reported medsurg — total net sales of $1.23B in Q1 2026.
- How has Solventum's medsurg — total net sales changed year-over-year?
- Solventum's medsurg — total net sales increased by 6.7% year-over-year, from $1.16B to $1.23B.
- What is the long-term trend for Solventum's medsurg — total net sales?
- Over 3 years (2022 to 2025), Solventum's medsurg — total net sales has grown at a 1.7% compound annual growth rate (CAGR), from $4.59B to $4.82B.
- What does medsurg — total net sales mean?
- Total revenue earned from MedSurg products after accounting for returns and discounts.
- How do you interpret medsurg — total net sales?
- Higher sales indicate strong market demand and successful product adoption.
- How does medsurg — total net sales compare across companies?
- Standard revenue metric used across all public companies to measure segment performance.